Home > News News

News and Press Releases

Read Veristat news and press releases to learn about our CRO service growth, geographic expansion in Europe and Asia, biotechnology preferred partnerships and small CRO acquisitions.

Veristat Names Industry Veteran Kim McLean Boericke as  New Chief Executive Officer

Boericke succeeds Patrick Flanagan, who is transitioning to the Board of Directors

Southborough, MA - Jan. 13, 2026 – Veristat, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced that Kim McLean Boericke has been named Chief Executive Officer (CEO). Boericke, an experienced executive with decades of leadership and operational experience in the clinical research industry, succeeds Patrick Flanagan.

Veristat and AOBiome Therapeutics to Present at Clinical Outsourcing Group on Essential...

Southborough, MA - Oct. 7, 2025 – Veristat, a global clinical research organization (CRO) and consultancy specializing in complex studies,...

Cook MyoSite and Veristat Partner in Complex, Phase III, Adaptive Clinical Study of...

Veristat partners to achieve key enrollment milestone for study; activated 26 sites and enrolled over 100 participants

Veristat Achieves EcoVadis Committed Badge: A Milestone in Our Sustainability Journey

We're proud to announce that Veristat has received our first EcoVadis Committed Badge, marking a significant milestone in our commitment to...

Veristat Congratulates George Medicines on FDA Approval of WIDAPLIK™

Proud to Collaborate in Delivering a Groundbreaking, First-in-Class Therapy to Patients in Need

Veristat Appoints Industry Veteran Kim McLean Boericke as its Chief Operating Officer

Accelerating Operational Excellence and Client Success

SOUTHBOROUGH, MA – October 30, 2024—Veristat, a scientific-minded global clinical...

Veristat Appoints Gabriela Rosu, M.D., to Lead Growing Medical Affairs Team

To support sponsors around the globe bringing novel treatments to patients

SOUTHBOROUGH, MA – May 29, 2024 – Veristat, the Science-First...

Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues...

Committed to a Science-First Approach to Support Patient Access to Life-Changing Therapies

Veristat Acquires Biometrics-focused Instat Clinical Research

Acquisition Will Power Data insights, Trial Optimization, and Value Across Clinical Development

Prev 1 2 3 4 5 Next